01—Abstract
Summary
Summary of the 10-K filed February 16, 2021. Cited figures are marked; the original filing is the authoritative source.
CVS Health Corporation's (CVS) 2020 10-K filing highlights a year of significant revenue growth, primarily driven by its Health Care Benefits and Retail/LTC segments.
Total revenues increased by 4.6% to $268.7 billiona, reflecting growth in membership and the impact of COVID-19-related services. The company demonstrated resilience despite the pandemic, with its Pharmacy Services segment showing improved purchasing economics and growth in specialty pharmacy, contributing to a 15.2% increase in operating income for that segment. The Health Care Benefits segment saw substantial growth, benefiting from increased Medicare membership and a favorable impact from government programs, although this was partially offset by the costs associated with the pandemic response and shifts in membership.
Despite facing challenges like reimbursement pressure in the Retail/LTC segment and incremental operating expenses due to COVID-19, CVS Health maintained a strong liquidity position with significant cash reserves and managed its debt effectively through repayment initiatives. The company's strategic focus on integrating its diverse health services, enhancing digital capabilities, and expanding its HealthHUB locations continues to shape its business model. CVS Health played a critical role in the COVID-19 response, offering widespread testing and preparing for vaccine administration, which contributed to its revenue and community presence.
The company also highlighted its commitment to its workforce through enhanced benefits and safety protocols during the pandemic. Looking ahead, CVS Health anticipates continued growth driven by its strategic initiatives, though it remains mindful of ongoing regulatory complexities and competitive pressures within the healthcare industry.
02—Key points
Key Highlights
- Total revenues increased by 4.6% to $268.7 billion in 2020, driven by growth in Health Care Benefits and Retail/LTC segments.
- Pharmacy Services segment operating income increased 15.2% due to improved purchasing economics and specialty pharmacy growth.
- Health Care Benefits segment saw a significant increase in operating income (42.0%) driven by Medicare membership growth and COVID-19 related impacts, partially offset by divestitures.
- The company actively managed its debt, repurchasing billions of dollars of senior notes throughout 2020.
- CVS Health played a key role in the COVID-19 response, offering diagnostic testing at over 4,000 locations and preparing for vaccine administration.
- The company experienced increased operating expenses related to its COVID-19 pandemic response efforts and the reinstatement of the health insurer fee (HIF).
- Despite economic volatility due to COVID-19, the company ended 2020 with approximately $7.9 billion in cash and cash equivalents.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2020, CVS Health Corp kept $0.03.
- Revenue$268.71B100.0%
- Cost of revenue−$163.98B61.0%
- Gross profit$104.72B39.0%
- Operating costs−$90.81B33.8%
- Operating income$13.91B5.2%
- Interest, other & tax−$6.72B2.5%
- Net income$7.19B2.7%
Where FY2020 revenue went
$268.71B- Cost of revenue: $163.98B, 61% of revenue
- Operating costs: $90.81B, 34% of revenue
- Net income: $7.19B, 2.7% of revenue
- Interest, other & tax: $6.72B, 2.5% of revenue
Kept 2.7% as net incomeNet income $7.19B · 2.7%
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2020filed February 16, 2021Financial Statements
FY2020 against FY2019
| Line item | FY2020FY2019 | Change |
|---|---|---|
| Revenue | $268.71B$256.78B | +4.6% |
| Cost of Revenue | $163.98B$158.72B | +3.3% |
| Gross Profit | $104.72B$98.06B | +6.8% |
| Operating Expenses | $254.79B$244.79B | +4.1% |
| Operating Income | $13.91B$11.99B | +16.1% |
| Interest Expense | $2.91B$3.04B | −4.2% |
| Net Income | $7.19B$6.63B | +8.4% |
| EPS (Basic) | $5.48$5.10 | +7.5% |
| EPS (Diluted) | $5.46$5.08 | +7.5% |
| Shares Outstanding (Basic) | 1.31B1.30B | +0.6% |
| Shares Outstanding (Diluted) | 1.31B1.30B | +0.7% |
05—Questions
Frequently Asked Questions
How did COVID-19 impact CVS Health's financial performance in 2020?
COVID-19 had a mixed impact. The Health Care Benefits segment saw reduced medical utilization due to deferred elective procedures, partially offset by COVID-19 related treatment costs and investments. The Retail/LTC segment experienced initial increases in prescription volume due to early refills and higher front-store sales as consumers prepared for the pandemic, followed by reduced customer traffic and new prescriptions due to shelter-in-place orders. The company also incurred incremental operating expenses for pandemic response efforts.
What was the significance of the Aetna acquisition to CVS Health's 2020 results?
The Aetna acquisition, completed in late 2018, continued to significantly shape CVS Health's financial results in 2020. The Health Care Benefits segment, largely comprised of Aetna's operations, drove substantial revenue growth and contributed significantly to the company's overall operating income. The integration of Aetna allowed CVS Health to offer a more comprehensive range of health services.
How did CVS Health manage its debt levels in 2020?
CVS Health actively managed its debt by issuing new senior notes and using the proceeds, along with existing cash, to repurchase billions of dollars of its outstanding senior notes through tender offers. This strategy aimed to optimize its capital structure and manage its debt-to-equity ratio.
What are the key challenges or risks identified in the filing for CVS Health?
Key challenges and risks include intense competition across all segments, pricing pressures and reimbursement challenges in the Pharmacy Services and Retail/LTC segments, potential changes in healthcare policy and regulations (including those related to Medicare and Medicaid), the ongoing impact of COVID-19 on utilization and costs, and the integration and performance of acquired businesses. The company also faces risks related to cybersecurity and data privacy.
06—Continue